Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Headache ; 46(3): 444-53, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16618262

RESUMO

OBJECTIVE: Compare the effectiveness of a combination analgesic containing acetaminophen, aspirin, and caffeine to that of ibuprofen in the treatment of migraine. METHODS: Multicenter, double-blind, randomized, parallel-group, placebo-controlled, single-dose study. A total of 1555 migraineurs were included in the analysis. No patients were excluded solely because of severity of symptoms or degree of disability. A single 2-tablet dose for each of the 3 treatment groups: a combination product containing acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg per tablet (AAC); ibuprofen 200 mg per tablet (IB); or matching placebo. The primary efficacy endpoint was the weighted sum of pain relief (PAR) scores at 2 hours postdose (TOTPAR2) and an important secondary endpoint was the time to onset of meaningful relief. RESULTS: There were 669 patients in the AAC group, 666 patients in the IB group, and 220 patients in the placebo group. The 3 treatment groups had similar demographic profiles, migraine histories, and baseline symptom profiles. While both active treatments were significantly better than placebo in relieving the pain and associated symptoms of migraine, AAC was superior to IB for TOTPAR2, as well as for PAR, time to onset of meaningful PAR, pain intensity reduction, headache response, and pain free. The mean TOTPAR2 scores for AAC, IB, and placebo were 2.7, 2.4, and 2.0, respectively (AAC vs. IB, P < .03). The median time to meaningful PAR for AAC was 20 minutes earlier than that of IB (P < .036). CONCLUSION: AAC and IB are safe, cost-effective treatments for migraine; AAC provides significantly superior efficacy and speed of onset compared with IB.


Assuntos
Acetaminofen/administração & dosagem , Analgésicos não Narcóticos/administração & dosagem , Anti-Inflamatórios não Esteroides/administração & dosagem , Aspirina/administração & dosagem , Cafeína/administração & dosagem , Estimulantes do Sistema Nervoso Central/administração & dosagem , Ibuprofeno/uso terapêutico , Transtornos de Enxaqueca/tratamento farmacológico , Adulto , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Humanos , Masculino
2.
Prim Care ; 31(2): 395-405, viii, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15172514

RESUMO

The authors have a personal philosophy that it is worthwhile for a physician on occasion to be the patient. When this particular physician consults another physician for a medical problem, he is seeking treatment to eradicate that particular problem. It is difficult to afford the appropriate therapy for that problem if the correct diagnosis is not made. It is exactly the same situation with patients that come to us with complaints of headache. If we cannot make the proper diagnosis, it is unlikely we will be able to render the appropriate therapy. We need to keep this in mind when we evaluate patients with these headache problems, many of whom have suffered with an incorrect diagnosis for many years.


Assuntos
Erros de Diagnóstico , Transtornos da Cefaleia/diagnóstico , Cefaleia/diagnóstico , Doença Aguda , Analgésicos/uso terapêutico , Doença Crônica , Cefaleia Histamínica/diagnóstico , Cefaleia Histamínica/terapia , Diagnóstico Diferencial , Cefaleia/epidemiologia , Transtornos da Cefaleia/epidemiologia , Humanos , Transtornos de Enxaqueca/diagnóstico , Atenção Primária à Saúde/normas , Qualidade de Vida , Fatores de Risco , Cefaleia do Tipo Tensional/diagnóstico , Estados Unidos/epidemiologia
3.
Headache ; 7(3): 131-132, 1967 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29508921
4.
Buenos Aires; Editorial Bernades; 1a. ed; 1980. 491 p. ^e26 cm.
Monografia em Espanhol | LILACS-Express | BINACIS | ID: biblio-1198133
5.
Buenos Aires; Editorial Bernades; 1a. ed; 1980. 491 p. 26 cm. (72845).
Monografia em Espanhol | BINACIS | ID: bin-72845
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...